Skip to main content
Tags: roseanne | ambien | public relations

Roseanne Drags Ambien Into Her PR Crisis

Roseanne Drags Ambien Into Her PR Crisis
Actress Roseanne Barr attends during 2018 Disney, ABC, Freeform Upfront on May 15, 2018, in New York City. (Dimitrios Kambouris/Getty Images)

By    |   Monday, 04 June 2018 11:14 AM EDT

In what’s certainly in the running for strangest headline so far this year, the manufacturer of the sleep aid Ambien issued a statement last week denying any claims that its product "causes racism." The headline read: “Racism is not a known side effect of Ambien.”

If you are unaware of the surrounding context, that statement might read like a "Saturday Night Live" sketch about the laundry list of potential side-effects of certain prescription drugs. But, no, it was an actual headline based on a statement in response to Roseanne Barr’s “defense” of the tweet that got her eponymous hit sitcom canceled last week.

Barr started her PR crisis response by vowing to stay off Twitter. That lasted a few hours.

Soon, she was back, tweeting out apologies and calling her comments “unforgivable” while asking her fans not to defend the comments. In the middle of all that, though, she was re-tweeting comments from fans complaining to ABC about the cancellation of the show. At some point, probably with humorous intent, she dropped the “explanation.” “It was two in the morning… I was Ambien tweeting…”

There have been some “interesting” reports of certain experiences people have had while taking Ambien, and the drug’s maker, Sanofi, has been careful to list precautions and side effects — including nausea, impaired vision, cramps, disorientation, and anxiety — but none of those come close to the Twitter equivalent of “drunk dialing.”

Many of Roseanne’s critics pounced on the excuse the TV star offered, while Ambien’s PR team was left crafting a serious, though clearly tongue-in-cheek response: “While all pharmaceutical treatments have side effects, racism is not a known side effect of any Sanofi medication…”

That statement proved far too enticing for most media outlets to pass up, taking the whole Roseanne debacle well into a fresh news cycle.

Later, the comedian amended her comment, saying: “I am to blame, not Ambien.”

While the series of tweets and PR statements proved to offer a little bit of levity and gave Roseanne an opportunity to point a little self-effacing humor back at herself in the face of withering criticism, the incident once again served to highlight the speed at which stories can be created, shifted, or influenced through social media, especially on a platform as “immediate” as Twitter.

It’s easy — and likely true — to assume both Roseanne and Sanofi tweeted with humor underlying their intent, but the sheer speed at which those comments became headlines and filled column inches in news publications and content for radio and TV hosts should be a lesson to anyone interested in maintaining control of the PR narrative and messaging around their brand.

Lose attention for the briefest of moments, and your story could quickly spin out of your control.

Ronn Torossian is one of America’s foremost Public Relations executives as founder/CEO of 5WPR, a leading independent public relations Agency. The firm was honored as PR Firm of the Year by The American Business Awards, and has been named to the Inc. 500 List. Torossian is author of the best-selling "For Immediate Release: Shape Minds, Build Brands, and Deliver Results with Game-Changing Public Relations." For more of Ronn Torossian's reports, Go Here Now.

© 2024 Newsmax. All rights reserved.


RonnTorossian
In what’s certainly in the running for strangest headline so far this year, the manufacturer of the sleep aid Ambien issued a statement last week denying any claims that its product "causes racism." The headline read: “Racism is not a known side effect of Ambien.”
roseanne, ambien, public relations
529
2018-14-04
Monday, 04 June 2018 11:14 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Interest-Based Advertising | Do not sell or share my personal information

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the NewsmaxTV App
Get the NewsmaxTV App for iOS Get the NewsmaxTV App for Android Scan QR code to get the NewsmaxTV App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved